Defiance Introduces 2X Daily Leveraged ETF Tracking Moderna Shares
Defiance launched the Daily Target 2X Long MRNA ETF, seeking to deliver 200% of Moderna share movements on a daily basis through a liquid, exchange-traded vehicle. The fund resets every trading day and targets short-term tactical exposure for sophisticated investors due to potential volatility and performance divergence over time.
1. ETF Launch
Defiance ETFs on Feb. 9 introduced the Daily Target 2X Long MRNA ETF (MRNX), offering two times daily exposure to Moderna shares within an exchange-traded structure.
2. Fund Structure and Mechanics
MRNX employs a daily reset mechanism to target 200% of Moderna’s share price movement each trading day, using a mix of equity derivatives to replicate leveraged exposure without margin accounts.
3. Target Investors and Risks
The ETF is aimed at sophisticated traders seeking short-term tactical positions, with potential for high volatility and tracking error over multi-day holds, making it unsuitable for long-term investors.